PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 71 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $208,000 | -33.8% | 2,650 | -36.4% | 0.00% | -25.0% |
| Q3 2015 | $314,000 | -35.4% | 4,165 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $486,000 | -68.2% | 4,165 | -35.6% | 0.01% | -66.7% |
| Q1 2015 | $1,526,000 | +15.8% | 6,465 | -7.2% | 0.02% | +28.6% |
| Q4 2014 | $1,318,000 | -33.5% | 6,965 | -16.1% | 0.01% | -36.4% |
| Q3 2014 | $1,981,000 | +1484.8% | 8,305 | +337.1% | 0.02% | +2100.0% |
| Q2 2014 | $125,000 | -64.7% | 1,900 | -44.1% | 0.00% | -80.0% |
| Q1 2014 | $354,000 | +162.2% | 3,400 | +161.5% | 0.01% | +150.0% |
| Q4 2013 | $135,000 | – | 1,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |